Bioniche Animal Health discovers, develops, manufactures and markets animal health products worldwide.
Headquartered in Canada, the Company was formed in 1979 to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Bioniche Animal Health is now a division of Bioniche Life Sciences Inc., a public company (TSX: BNC and ASX: BNC).
Bioniche Animal Health markets a broad portfolio of products for companion animals, horses and the livestock industry, with a focus on four key areas:
01 May 2012
Bioniche Life Sciences Inc.
BELLEVILLE, ON, May 1, 2012 – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company,... [read more]
01 May 2012
New supplement promotes gastrointestinal self-healing in horses
Belleville, Ontario, March 9, 2012 – A new botanical based product is now available in the United States that will... [read more]
27 April 2012
Celox Veterinary™ – Stops Arterial and Venous Bleeding Fast
Belleville, Ontario, April 27, 2012 – Celox Veterinary™, a new product that quickly stops bleeding, has been launched in North... [read more]
view all recent news
 |
|||
|
|||
 |
|
|||
|
|||
|
|
|||
|
|||
|
|
|||
|
|||
|
2011 © Bioniche Animal Health a division of Bioniche Life Sciences. All rights reserved.
Google translate
